Does The Dosing Frequency of Proton Pump Inhibitors (PPIs) Affect Susequent Resource Utilization and Costs Among Patients Diagnosed with Gastroesophageal Reflux Disease (GERD)? | Abt Associates

Skip to main content

This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Does The Dosing Frequency of Proton Pump Inhibitors (PPIs) Affect Susequent Resource Utilization and Costs Among Patients Diagnosed with Gastroesophageal Reflux Disease (GERD)?

Boulanger L1, Mody R2, Bao Y1, Ancukiewicz V1, Russell MW1

Abt Associates Inc., Lexington, MA, USA

Presentation

Download

June 1, 2008